Your browser doesn't support javascript.
loading
G protein-coupled receptor 40 expression in human melanoma - correlation with tumour thickness, AJCC stage and survival.
Kleemann, J; Hrgovic, I; Kleimann, P; Ter-Nedden, J; Glaser, M; Steinhorst, K; Härle, K; Müller, J; Kaufmann, R; Kippenberger, S; Meissner, M.
Afiliação
  • Kleemann J; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Hrgovic I; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Kleimann P; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Ter-Nedden J; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Glaser M; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Steinhorst K; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Härle K; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Müller J; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Kaufmann R; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Kippenberger S; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
  • Meissner M; Department of Dermatology, Venereology and Allergy, Goethe University Hospital, Frankfurt/Main, Germany.
J Eur Acad Dermatol Venereol ; 34(2): 285-292, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31465594
ABSTRACT

BACKGROUND:

In melanoma, preclinical data suggest a possible role of polyunsaturated fatty acids inhibiting cell growth. A new target molecule for free fatty acids, the G protein-coupled receptor GPR40, was identified in melanoma cells.

OBJECTIVES:

The aim of this study was to investigate GPR40 expression in human melanocytic tissues and to evaluate its potential as a prognostic marker. METHODS AND

RESULTS:

A total of 114 tissue sections of naevi, primary melanoma and melanoma metastasis were immunohistochemically stained with anti-GPR40. The staining was evaluated, using the immunoreactivity scoring system. Compared to naevi, primary melanoma and melanoma metastasis showed significantly higher levels of GPR40 (P < 0.05). In primary melanoma, GPR40 expression positively correlated with tumour thickness (P = 0.044) and AJCC level (P = 0.017) and in melanoma metastasis with AJCC level (P = 0.035). Primary melanoma patients with high levels of GPR40 had a significantly poorer overall survival (P = 0.004) and shorter disease-free survival (0.040).

CONCLUSION:

The present study identified GPR40 as a novel target molecule in melanoma. First evidence for a potential role of the receptor in tumour progression and metastases was found, and it could be demonstrated that GPR40 expression is negatively correlated with patient's survival.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptores Acoplados a Proteínas G / Melanoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Receptores Acoplados a Proteínas G / Melanoma Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article